Trial intelligence / Profile preview

IVRA with lidocaine plus dexmedetomidine and/or nitroglycerin for hand or forearm surgery

ACTRN12616000838415Phase 4Suspended

Sponsor
Hoda Alsaid Ahmed Ezz
Start
Jun 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of lidocaine, dexmedetomidine and nitroglycerin in acute pain, sponsored by Hoda Alsaid Ahmed Ezz. Primary endpoints: Duration of analgesia, Tourniquet pain and 1 more. Started Jun 2016; status: suspended.

02

Drugs

lidocainedexmedetomidinenitroglycerin
03

Conditions

acute pain

Beyond the preview

Go deeper on ACTRN12616000838415.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12616000838415.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call